CYPROLARA Drug Patent Profile
When do Cyprolara patents expire, and what generic alternatives are available?
Cyprolara is a drug marketed by Quagen and is included in one NDA.
The generic ingredient in CYPROLARA is cyproheptadine hydrochloride. There is one drug master file entry for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cyproheptadine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cyprolara
A generic version of CYPROLARA was approved as cyproheptadine hydrochloride by CHARTWELL RX on May 26th, 1983.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CYPROLARA?
- What are the global sales for CYPROLARA?
- What is Average Wholesale Price for CYPROLARA?
Summary for CYPROLARA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 6 |
| DailyMed Link: | CYPROLARA at DailyMed |
US Patents and Regulatory Information for CYPROLARA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quagen | CYPROLARA | cyproheptadine hydrochloride | TABLET;ORAL | 212491-002 | Oct 2, 2026 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
